About this trial
Sleep and circadian problems are associated with deleterious social, emotional, and cognitive outcomes, yet are modifiable. This prospective study will adapt and optimize an empirically supported behavioral intervention that addresses common sleep and circadian problems of autistic adults, who are at increased risk for mental health disorders, using a transdiagnostic approach. The knowledge gained from this study will help to address a critical need for accessible transdiagnostic sleep interventions for autistic adults, who experience a broad range of sleep and circadian problems at high rates and often lack access to specialty care treatment.
Eligibility criteria
Qualifiers
Autistic adults diagnosed with ASD.
Between the ages of 18 and 65 years.
English-speaking
One or more sleep or circadian problem(s) for a period of at least 3 months assessed with the Sleep and Circadian Problems Interview.
Disqualifiers
A history of IQ < 70.
A history of psychotic, bipolar or seizure disorders as per medical record.
Untreated sleep apnea, a history of narcolepsy, or restless legs syndrome, as per structured interview based on risk screeners.
Trial design
Treatments tested in this trial
- Transdiagnostic Intervention for Sleep and Circadian Dysfunction
Treatment groups
Locations
Sponsors and collaborators
Milton S. Hershey Medical Center
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator